Effect on ambulation of continuous intrathecal baclofen infusion?

Pediatric Neurosurgery

Volumn 27, Issue 1, 1997, Pages 40-44

  Gerszten, Peter C ^a   Albright, A Leland ^a   Barry, Margaret J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Ambulation; Baclofen; Cerebral palsy; Traumatic brain injury

Indexed keywords

BACLOFEN;

AMBULATORY CARE; ARTICLE; BRAIN INJURY; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFECT; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOBILIZATION; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD INJURY; VOLUNTARY MOVEMENT;

EID: 0031431490     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000121223     Document Type: Article

References (28)

1. Gage JR: Gait Analysis in Cerebral Palsy. London, MacKeith Press, 1991, pp 1-2.
2. Ordia JI, Fischer E, Adamski E, Spatz E: Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996;85:452-457.
3. Albright AL: Baclofen in the treatment of cerebral palsy. J Child Neurol 1996; 11:77-83.
4. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J: Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-2477.
5. Azouvi P, Mane M, Thiebaut J-B. Denys P, Remy-Neris O. Busscl B: Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and longterm follow-up. Arch Phys Med Rchabil 1996; 77:35-39.
6. Campbell SK. Almeida GL, Penn RD. Corcos DM: The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 1995;75:352-362.
7. Coffey RJ. Cahill D. Steers W. et al: Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J Neurosurg 1993;78:226-232.
8. Latash ML. Penn RD. Corcos DM, Gottlieb GL: Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990;72:388-392.
9. Lazorthcs Y, Salierin-Cautc B. Verdie J-C. Bas-tide R. Carillo J-P: Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
10. Loubser PG, Narayan RK. Sandin KJ, Donovan WH, Russel KD: Continuous infusion of intrathecal baclofen: Long-term effects on spasticity in spinal cord injury. Paraplegia 1991:29: 48-64.
11. Penn RD: Intrathecal baclofen for spasticity of spinal origin: Seven years of experience. J Neurosurg 1992;77:236-240.
12. Shctter AG: Intrathecal baclofen in the treatment of spasticity of spinal origin: Rationale, surgical techniques, and patient monitoring. Perspect Neurol Surg 1993:4:109-122.
13. Steinbok P. Armstrong R. Farrell K. Reiner A, Cochrane D: Intrathecal baclofen for treatment of spasticity in children: Report of nine cases. Can J Neurol Sci 1991:18:232.
14. Burke D: Spasticity as an adaptation to pyramidal tract injury; in Waxman SG (ed): Functional Recovery in Neurological Disease. New York, Raven Press. 1988, pp 401-423.
15. Landau WM: Parables of palsy pills and PT pedagogy: A spastic dialectic. Neurology 1988; 38:1496-1499.
16. Albright AL. Cervi A, Singletary J: Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991:265:1418-1422.
17. Ashworth B: Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964; 192: 540-542.
18. Hoffer MM. Feiwell E. Perry R. Perry J, Bonnet! C, Downey C: Functional ambulation in patients with myelomeningocele. J Bone Joint Surg 1973;55A: 137-148.
19. Shelter AG: The neurosurgical treatment of spasticity. Neurosurgery 1996;6:194-207.
20. Peacock WJ. Arens LJ. Berman B: Cerebral palsy spasticity: Selective posterior rhizotomy. Pediatr Neurosci 1987;13:61-66.
21. Penn RD, Kroin JS: Intrathecal baclofen alleviates spinal cord spasticity (letter). Lancet 1984;vol i: 1078.
22. Penr, RD. Savoy SM, Corcos D. et al: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989:320:1517-1521.
23. Albrghl AL, Barry MJ, Fasick MP, Janosky J: Effects of continuous intrathecal baclofen therapy and selective posterior rhizotomy on upper extremity spasticity. Pediatr Neurosurg 1995; 23:82-85.
24. Van Hemert JCJ: A double-blind comparison of baclofen and placebo in patients with spasticity of cerebral origin; in Feldman RG, Young RR. Koella WP (eds): Spasticity: Disordered Motor Control. Chicago, Yearbook, 1984, pp 41-49.
25. Bodcnstciner JB: The management of cerebral palsy: Subjectivity and a conundrum. J Child Neurol 1996:11:75-76.
26. Meythaler JM. Steers WD, Tuel SM. et al: Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rchabil 1992,73:794-797.
27. Landau WM: Spasticity: The fable of a neurological demon and the emperor’s new therapy. Arch Neurol 1974:31:217-219.
28. Dietz V: Spasticity: Exaggerated reflexes or movement disorder?: in Forssberg H. Hirsch-feld H (eds): Movement Disorders in Children. Basel. Karger. 1992, pp 225-233.